Stock Spotlight Archives - Page 81 of 379

FridayOct 21, 2022 3:16 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Holds Potential to Represent Multiple Commercial Opportunities

Lexaria Bioscience Corp. (NASDAQ: LEXX), a drug delivery platform innovator, last year announced a review of its successful 2021 antiviral drug program. “Lexaria specifically probed the bioavailability of five DehydraTECH(TM)-processed antiviral drugs for SARS-CoV-2, HIV/AIDS and other infectious diseases from three drug classes, evidencing significant gains with up to a three-fold increase in oral drug delivery into the bloodstream. The demonstrated improvements in absorption, Lexaria believed, could have significant commercial potential considering that many antiviral drugs typically show low oral bioavailability in their available form because of significant liver biotransformation and/or poor intestinal uptake,” reads a recent article. “Lexaria’s vision…

FridayOct 21, 2022 3:05 pm

QualityStocksNewsBreaks – HeartBeam Inc.’s (NASDAQ: BEAT) Patented Breakthrough Technology Poised to Disrupt ECG Patch Market

HeartBeam (NASDAQ: BEAT) recently received a patent from the United States Patent and Trademark Office for its 12-lead electrocardiogram (“ECG”) patch monitor for the detection of acute coronary syndrome (“ACS”) and cardiac arrhythmia. “The new patent expands on a previously granted patent for a 12-lead ECG patch monitor technology. HeartBeam noted that the patent opens a pathway to a disruptive ischemia and arrhythmia detection ECG patch product. In addition, the innovation builds on HeartBeam’s growing intellectual property portfolio that could enable 12-lead ECG diagnostics outside of a medical setting… Currently, the ECG patch monitor market is limited to detecting arrhythmias…

FridayOct 21, 2022 2:53 pm

QualityStocksNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Continually Upgrading Systems, Gaming Content to Maintain Competitive Edge

Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, is leveraging the growth opportunity that has arisen as casino operators embrace digital avenues. “Golden Matrix’s GM-AG System is the industry standard for gaming platforms, including leading graphics and over 10,000 games to give casino operators a copious number of options and management software to keep customers happy and loyal to their brand. As a rule, casinos can’t have enough online table games, which is right in GMGI’s wheelhouse… Golden Matrix is only scratching the surface of the bounds of its potential domain. Most…

FridayOct 21, 2022 12:09 pm

QualityStocksNewsBreaks – GeoSolar Technologies Inc. Well Positioned to Respond to Rising Market Demand for Sustainable Living

GeoSolar Technologies, a Colorado-based climate technology company, is stepping in and taking up the challenge to bring more sustainable living into American homes. “Homeowners increasingly seek to ensure that their everyday lifestyle is part of the solution rather than making the climate crisis worse than it already is. In their attempt to contribute to resolving this challenge, they often work to retrofit their existing houses and bring them to ‘net-zero energy’ status – which means an environmentally sustainable house that creates at least as much energy as it consumes… Proponents claim multiple benefits of such a way of living. These…

ThursdayOct 20, 2022 3:07 pm

QualityStocksNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Eyes Path to a Billion Dollars in Market Cap

Correlate Infrastructure Partners (OTCQB: CIPI), a portfolio-scale real estate platform, has achieved tremendous growth over the past few years. “This growth has been primarily attributed to the company’s understanding of the renewable energy market and the competence of its leadership, starting with Todd Michaels, Correlate’s president and CEO… Todd (while appearing in an interview published on the company’s website) notes, Correlate is committed to solving two main problems that corporations and companies, including the government, face regarding clean energy generation – how to generate clean energy on-site and how to set up better technology including new infrastructure that runs off…

WednesdayOct 19, 2022 2:50 pm

QualityStocksNewsBreaks – REZYFi Inc.’s Diversified Approach Positions It to Capitalize on Growth Across Multiple Verticals

REZYFi, a mortgage lender company servicing the needs of both traditional and non-traditional consumers and businesses, is positioned to be one of the first cannabis mortgage bankers in the United States. In this industry, many traditional lenders are reticent to serve the state-licensed cannabis sector. “REZYFi operates through two wholly owned subsidiaries: REZYFi Lending and ResMac Inc. Leveraging a wide network to offer options such as 15- and 30-year fixed-rate loans, FHA and VA loans, reverse mortgages, jumbo loans, and adjustable-rate mortgages, REZYFi Lending expects increased funding in marketing and loan agents to drive origination growth over the next two…

WednesdayOct 19, 2022 2:12 pm

QualityStocksNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Anticipates Leadership Position in Alternative Cannabinoid Market Segment

Flora Growth Corp. (NASDAQ: FLGC), a global cannabis cultivator, product manufacturer and distributor, is measuring its success in rapidly rising revenues brought on by strategic acquisitions and the expanding international movement of its brands. “The company recently reported a 604% increase YoY in its H1 revenues to about $15 million, which was also a 117% increase over the previous half-year financial report, and is anticipating new momentum from the recent acquisition of the No Cap Hemp Co. brand by Flora’s wholly owned subsidiary Just Brands LLC. The No Cap acquisition is expected to add some 75 SKUs to Flora’s product…

WednesdayOct 19, 2022 1:57 pm

QualityStocksNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Driving Green Ammonia Production, Adoption of Sustainable Agricultural Practices

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF), a clean energy solutions provider and technology company, is championing the limitation in the overuse of fertilizer for adopting more environmentally friendly agricultural practices. “On its part, FuelPositive has taken a multi-pronged approach that aims to produce green ammonia and push for the adoption of sustainable agricultural practices that eliminate pollution… FuelPositive has developed an on-farm, containerized, green ammonia production system that decarbonizes ammonia production by relying on renewable electricity to synthesize hydrogen and nitrogen from water and air, respectively, before combining the molecules in a converter to create green ammonia. The system also provides…

MondayOct 17, 2022 1:35 pm

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Continues Focus to Create the Best Psychedelic Therapies for Patients

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, is conducting a phase 1/2a trial evaluating CYB003, its lead investigational molecule and the first-ever novel psilocybin analog to enter clinical development. “The in-human trial is critical to the company’s continued development of CYB003, a deuterated psilocybin analog that Cybin believes has potential to successfully address the challenges and limitations of oral psilocybin. According to the company’s preclinical research, CYB003 achieved less variability in plasma levels, along with faster onset of action, improved brain penetration, and shorter duration…

MondayOct 17, 2022 1:05 pm

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Anticipating 2023 IND Application for Secondary Portfolio Candidate

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical innovator, is currently conducting a potentially pivotal global phase 2 clinical trial in humans to test the effectiveness of its anti-glioblastoma (“GBM”) drug candidate – Berubicin. Testing of Berubicin resulted in a notable success with evidence of improved survival among a dozen safety trial participants recruited by the drug’s original developer over 15 years ago. In its annual stockholder meeting, the company also provided an update for its secondary drug portfolio WP1244. The anthracycline-based substance, being evaluated for the treatment of brain cancers, ovarian and lymphomas, “has produced a new derivative as WP1874 with…

Site Search

Company Search

Category: Stock Spotlight